Flow
Cytometry Market by increasing applications in healthcare along with the
increasing number of cancer cases is projected to boost the market growth at a
healthy CAGR of ~ 11.5 %.
For instance, in January 2016,
Sysmex America Inc. has introduced New CyFlow monoclonal antibodies in the
market, this new reagent was introduced in the American market which will be
available for use in academic as well as clinical research and commercial
manufacturing.
The global
flow cytometry market has been segmented on the basis of products &
services, technology, application, and end-user.
On the basis of products &
services, the market has been classified as reagents and consumables, flow
cytometry instruments, services, software, and accessories. The flow cytometry
instruments segment has been further divided into cell analyzers and cell
sorters.
Avail
Sample Copy of this Report at: https://www.marketresearchfuture.com/sample_request/6433
The market by technology has been
divided into cell-based flow cytometry and bead-based flow cytometry.
The application segment has
been divided into research applications, clinical applications, and industrial
applications. The research applications segment has been segmented into
pharmaceutical and biotechnology and immunology. The pharmaceutical and
biotechnology sub-segment has been divided into drug discovery, stem cell
research, and in vitro toxicity testing.
Furthermore, the immunology
segment has been sub-segmented into cell sorting, apoptosis, cell cycle
analysis, cell viability, cell counting, and other research applications. The
clinical applications segment includes cancer, hematology, immunodeficiency
diseases, organ transplantation, and other clinical applications.
Geographical
Segmentation by Regions are as follows, Americas is expected
to dominate the global flow cytometry market during the forecast period owing
to the technological advancement, increasing prevalence of autoimmune diseases,
and well-established healthcare sector in the region. The European market is
expected to be the second-largest due to the increasing number of cancer
patients in the region and government funding and support of the healthcare
sector.
Moreover, the market in
Asia-Pacific is anticipated to be the fastest-growing during the forecast
period owing to increasing awareness about healthcare, increasing research and
development activities and favorable government initiatives for the
establishment of healthcare facilities. The market in the Middle East &
Africa is likely to account for the smallest share of the global flow cytometry
market.
Some of
the key players in the flow cytometry are Beckman Coulter,
Inc., Becton, Dickinson and Company., Danaher., Thermo Fisher Scientific, Merck
KGaA, Bio-Rad Laboratories, Inc., Luminex Corporation., Miltenyi Biotec, Sysmex
Partec GmbH Agilent Technologies, Inc., Sony Corporation, Biomérieux S.A., and
Enzo Biochem Inc.
Brows Full
Detailed Report at: https://www.marketresearchfuture.com/reports/flow-cytometry-market-6433
The high costs associated with
flow cytometry instruments and reagents, lack of awareness about applications
of flow cytometry and a shortage of technicians may hamper the growth of the
market during the assessment period.
About
Market Research Future:
At Market Research Future (MRFR),
we enable our customers to unravel the complexity of various industries through
our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
No comments:
Post a Comment